Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial

被引:105
作者
Kwiecien, M [1 ]
Edelman, A [1 ]
Nichols, MD [1 ]
Jensen, JT [1 ]
机构
[1] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA
关键词
oral contraceptives; continuous cycle; randomized; levonorgestrel; bleeding; acceptability;
D O I
10.1016/S0010-7824(02)00445-6
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The purpose of this study is to compare bleeding patterns and acceptability of a contraceptive regimen of combined 20 mug ethinyl estradiol/100 mug levonorgestrel taken with and without a hormone-free interval. Thirty-two women desiring oral contraception were randomized to six 28-day cycles (standard group) or 168 days without a pill-free interval (continuous group). Participants kept a daily bleeding calendar documenting bleeding events (none, spotting or required sanitary protection) and side effects (headache, nausea, breast tenderness, depression, premenstrual syndrome and bloating). Primary outcome was number of bleeding days. Secondary outcomes included bleeding days requiring sanitary protection, amenorrhea, patient acceptability of bleeding patterns, method satisfaction and affective side effects. There were no differences in the baseline characteristics of the two groups. Although total bleeding days were fewer in the continuous group (mean = 25.9 vs. 34.9 days), this result did not reach statistical significance. However, women in the continuous group reported significantly fewer bleeding days that required protection (18.4 vs. 33.8 days, p < 0.01), and were more likely to have amenorrhea. Although both groups reported a high level of satisfaction with bleeding patterns and side effect profiles, women in the continuous group reported significantly fewer days of bloating (0.7 vs. 11.1 days, p = 0.04), and menstrual pain (1.9 vs. 13.3 days, p < 0.01). Continuous use of 20 mug ethinyl estradiol/100 mug levonorgestrel is associated with less bleeding requiring protection, and more amenorrhea than standard administration. Taken with or without a hormone-free interval, this oral contraceptive formulation is highly acceptable with regard to bleeding patterns and side effect profile. The continuous group had fewer light and moderate bleeding days, less bloating and menstrual pain. For patients who are seeking these results, this method may be more desirable. (C) 2003 Elsevier Science Inc. All rights reserved,
引用
收藏
页码:9 / 13
页数:5
相关论文
共 23 条
[11]   A comparison of mechanisms underlying disturbances of bleeding caused by spontaneous dysfunctional uterine bleeding or hormonal contraception [J].
Fraser, IS ;
Hickey, M ;
Song, JY .
HUMAN REPRODUCTION, 1996, 11 :165-178
[12]   Emerging evidence on oral contraceptives and arterial disease [J].
Heinemann, LAJ .
CONTRACEPTION, 2000, 62 (02) :29S-36S
[13]  
Hulley SB, 1988, DESIGNING CLIN RES
[14]   CLINICAL COMPARISON OF 2 LOW-DOSE ORAL-CONTRACEPTIVES, MINULET(R) AND MERCILON(R), IN WOMEN OVER 30 YEARS OF AGE [J].
KIRKMAN, RJE ;
PEDERSEN, JH ;
FIORETTI, P ;
ROBERTS, HE .
CONTRACEPTION, 1994, 49 (01) :33-46
[15]   ACCEPTABILITY OF AN ORAL-CONTRACEPTIVE THAT REDUCES FREQUENCY OF MENSTRUATION - TRI-CYCLE PILL REGIMEN [J].
LOUDON, NB ;
FOXWELL, M ;
POTTS, DM ;
GUILD, AL ;
SHORT, RV .
BRITISH MEDICAL JOURNAL, 1977, 2 (6085) :487-490
[16]  
MacGregor A, 2000, FUNCT NEUROL, V15, P143
[17]   Internet availability of contraceptives [J].
Miller, L ;
Nielsen, C .
OBSTETRICS AND GYNECOLOGY, 2001, 97 (01) :121-126
[18]   Menstrual reduction with extended use of combination oral contraceptive pills: Randomized controlled trial [J].
Miller, L ;
Notter, KM .
OBSTETRICS AND GYNECOLOGY, 2001, 98 (05) :771-778
[19]   A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 μg levonorgestrel with 20 μg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol [J].
Reisman, H ;
Martin, D ;
Gast, MJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (05) :S45-S52
[20]   The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices [J].
Rivera, R ;
Yacobson, I ;
Grimes, D .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1999, 181 (05) :1263-1269